- Phare
 - Validé par KD/KO
 
Anticorps Polyclonal de lapin anti-BID
BID Polyclonal Antibody for WB, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain et plus (3)
Applications
WB, IHC, IF, IP, ELISA
Conjugaison
Non conjugué
N° de cat : 10988-1-AP
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en WB | cellules A431, cellules A549, cellules HEK-293, cellules HeLa traitées à la tunicamycine, cellules HepG2, cellules Jurkat, tissu cérébral humain | 
| Résultats positifs en IP | cellules HeLa, | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 | 
| Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Applications publiées
| WB | See 59 publications below | 
| IHC | See 3 publications below | 
| IF | See 1 publications below | 
Informations sur le produit
10988-1-AP cible BID dans les applications de WB, IHC, IF, IP, ELISA et montre une réactivité avec des échantillons Humain
| Réactivité | Humain | 
| Réactivité citée | rat, Humain, porc, souris | 
| Hôte / Isotype | Lapin / IgG | 
| Clonalité | Polyclonal | 
| Type | Anticorps | 
| Immunogène | BID Protéine recombinante Ag1445 | 
| Nom complet | BH3 interacting domain death agonist | 
| Masse moléculaire calculée | 22 kDa | 
| Poids moléculaire observé | 22 kDa | 
| Numéro d’acquisition GenBank | BC009197 | 
| Symbole du gène | BID | 
| Identification du gène (NCBI) | 637 | 
| Conjugaison | Non conjugué | 
| Forme | Liquide | 
| Méthode de purification | Purification par affinité contre l'antigène | 
| Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol | 
| Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. | 
Informations générales
BID, also named as p22 BID, can be cleaved into p11 BID, p13 BID and p15 BID. It is pro-apoptotic molecules. The major proteolytic product p15 BID allows the release of cytochrome c. BID-L, BID-EL and BID-ES induce ICE-like proteases and apoptosis. BID-S does not induce apoptosis. BID counters the protective effect of Bcl-2. (PMID:14583606)
Protocole
| Product Specific Protocols | |
|---|---|
| WB protocol for BID antibody 10988-1-AP | Download protocol | 
| IP protocol for BID antibody 10988-1-AP | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
Publications
| Species | Application | Title | 
|---|---|---|
Bioact Mater A ROS-responsive, self-immolative and self-reporting hydrogen sulfide donor with multiple biological activities for the treatment of myocardial infarction. | ||
Environ Pollut Silica nanoparticles inducing the apoptosis via microRNA-450b-3p targeting MTCH2 in mice and spermatocyte cell. | ||
Cell Mol Life Sci Clostridioides difficile toxin B alone and with pro-inflammatory cytokines induces apoptosis in enteric glial cells by activating three different signalling pathways mediated by caspases, calpains and cathepsin B. | ||
Int J Cancer Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. | ||
Free Radic Biol Med Shikonin, a Chinese plant-derived naphthoquinone, induces apoptosis in hepatocellular carcinoma cells through reactive oxygen species: A potential new treatment for hepatocellular carcinoma. | ||
Stem Cell Res Ther Adipose-derived stem cells alleviate radiation-induced dermatitis by suppressing apoptosis and downregulating cathepsin F expression. | 





